checkAd
    Startseite > Aktien > Telix Pharmaceuticals > Nachrichten
    Telix Pharmaceuticals Aktie
    9,7760
     
    EUR
    +0,64 %
    +0,0620 EUR
    Letzter Kurs 15:31:14 Tradegate
    9,6520
     
    EUR
    322 STK
    Geldkurs 15:31:17
    9,7760
     
    EUR
    309 STK
    Briefkurs 15:31:17
    ISIN: AU000000TLX2 · WKN: A2H7JK · SYM: T3X · Australien

    Neueste Nachrichten

    Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
    21.05.24 · globenewswire · Telix Pharmaceuticals
    Telix Files Registration Statement for Proposed Initial Public Offering in the United States
    17.05.24 · globenewswire · Telix Pharmaceuticals
    Q1 2024 Revenue and Business Update
    17.04.24 · globenewswire · Telix Pharmaceuticals
    wO Börsenlounge : Barrick Gold | Telix | Fresenius - Intel eifert Nvidia nach!
    16.04.24 · Markus Weingran · Barrick Gold Corporation
    TLX101-CDx (Pixclara) Granted FDA Fast Track Designation
    16.04.24 · globenewswire · Telix Pharmaceuticals
    World First Use of Lightpoint's SENSEI Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
    26.03.24 · globenewswire · Telix Pharmaceuticals
    QDOSE Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy
    18.03.24 · globenewswire · Telix Pharmaceuticals
    Appointment of Dr Darren Patti to Group Chief Operating Officer
    11.03.24 · globenewswire · Telix Pharmaceuticals
    Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
    04.03.24 · globenewswire · Telix Pharmaceuticals
    Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
    26.02.24 · globenewswire · Telix Pharmaceuticals
    Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline
    22.02.24 · globenewswire · Telix Pharmaceuticals
    Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
    07.02.24 · globenewswire · Telix Pharmaceuticals